List of Fate Therapeutics patents | 7 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11365394 Enhanced immune effector cells and use thereof	Patent 11365394 was granted and assigned to Fate Therapeutics on June, 2022 by the United States Patent and Trademark Office.	Fate Therapeutics	Fate Therapeutics	United States Patent and Trademark Office	11365394	June 21, 2022
‌ US Patent 11413309 Compositions and methods for immune cell modulation in adoptive immunotherapies	Patent 11413309 was granted and assigned to Fate Therapeutics on August, 2022 by the United States Patent and Trademark Office.	Fate Therapeutics	Fate Therapeutics	United States Patent and Trademark Office	11413309	August 16, 2022
‌ US Patent 11352607 Genomic engineering of pluripotent cells	Patent 11352607 was granted and assigned to Fate Therapeutics on June, 2022 by the United States Patent and Trademark Office.	Fate Therapeutics	Fate Therapeutics	United States Patent and Trademark Office	11352607	June 7, 2022
‌ US Patent 11441126 Platform for the induction and maintenance of ground state pluripotency		Fate Therapeutics	Fate Therapeutics	United States Patent and Trademark Office	11441126	September 13, 2022
‌ US Patent 11268069 Reprogramming methods and cell culture platforms	Patent 11268069 was granted and assigned to Fate Therapeutics on March, 2022 by the United States Patent and Trademark Office.	Fate Therapeutics	Fate Therapeutics	United States Patent and Trademark Office	11268069	March 8, 2022
‌ US Patent D998174 Vial rack	Patent D998174 was granted and assigned to Fate Therapeutics on September, 2023 by the United States Patent and Trademark Office.	Fate Therapeutics	Fate Therapeutics	United States Patent and Trademark Office	D998174	September 5, 2023
‌ US Patent 11634688 Methods and compositions for inducing hematopoietic cell differentiation	Patent 11634688 was granted and assigned to Fate Therapeutics on April, 2023 by the United States Patent and Trademark Office.	Fate Therapeutics	Fate Therapeutics	United States Patent and Trademark Office	11634688	April 25, 2023